T Kalamatas

  • Citations Per Year
Learn More
BACKGROUND Previous studies on Natalizumab (NAT) have shown increased circulation of most white blood cells (WBC) in multiple sclerosis (MS) patients shortly after its introduction. AIM To describe peripheral immune cell phenotypes after more than 2 years of continuous NAT therapy and test for associations with clinical response to therapy. METHODS(More)
Purpose/background/objectives Our main goal is to study the comorbidity of headache and MS. We investigated possible correlations between MS clinical course and headache characteristics. Headache is a common complaint between Multiple Sclerosis (MS) patients. It has been found that headache prevalence during MS is above 50 % and this is different from the(More)
  • 1